您要查找的是不是：
- 脂溶性茶多酚中的主要活性組分及對人卵巢癌HO-8910細胞株的體外抑制活性The Main Active Component of Lipophilic Tea Polyphenols and in vitro Inhibition Activity on Ovarian Cancer Cells HO-8910
- 卵巢癌HO-8910細胞HO-8910 ovary carcinoma cell
- 人卵巢癌HO-8910細胞HO-8910 cell
- TAM和DDP聯(lián)合用可有效抑制HO-8910細胞生長(cháng)及增殖。TAM combined with DDP suppressed the growth and proliferation of the cell HO-8910 efficiently.
- AZT作用后的 HO-8910細胞端粒酶活性明顯受抑制 ,且細胞的 G2 /M期 DNA含量明顯增高 .Telomerase activity of HO-8910 cells was significantly inhibited when treated with AZT, and cell cycle of treated HO-8910 cells was changed with marked increase in G 2/M phase.
- 卵巢癌p27ovarian carcinoma p27
- 卵巢癌基因1ovarian cancer gene 1 (OVCA1)
- 免疫組化結果顯示:正常的HO一8910細胞FaS和Fas一L染色均為陰性; 而HO一8910一Fcy::Fur在加入5一FC4天后，Fas和Fas一L染色均為陽(yáng)性。The expression of Fas and FasL showed positive in HO-8910-Fcy::Fur after the 96 hours administration of 5-FC compared with negative in normal HO-8910 by immunohistochemical assay.
- 上皮性卵巢癌Epithelial ovarian cancer
- 酸性成纖維細胞生長(cháng)因子在卵巢癌中的表達及其信號傳導途徑Expression of aFGF in ovarian epithelial cancer and its signal transduction pathway
- DOC-2對卵巢癌細胞HO-8910致瘤力的影響The impact of DOC-2 expression on the tumorigenesis of human ovarian cancer cell line(HO-8910)
- 粘液性卵巢癌mucous ovarian cancer
- 卵巢癌耐藥細胞ovarian carcinoma drug-resistant cell
- 原發(fā)性卵巢癌診斷Diagnosis of ovarian neoplasm
- 人卵巢癌SKOV-3細胞human ovarian cancer SKOV-3 cell
- 卵巢癌的免疫治療進(jìn)展Progress on Immunization Therapy of the Ovary Cancer
- 順鉑誘導卵巢癌COC1細胞凋亡的觀(guān)察Patterns of Cisplatin Induced Apoptosis in Ovarian Cancer Cell Line COC 1
- 卵巢癌再次手術(shù)探查術(shù)Second look operation for ovarian cancer
- 晚期卵巢癌理想腫瘤細胞減滅術(shù)的可行性研究A Clinical Study of Maximum Cytoreductive Surgery for Advanced Ovarian Cancer
- 卵巢癌外科手術(shù)新看法Taking a New Look at Surgical Management of Ovarian Cancer
